African Swine Fever Virus (ASFV): Pathogenesis, Real-Time PCR Diagnostics, and Biosecurity
Primary Keyword: african swine fever virus diagnostics
Executive Summary
African swine fever virus (ASFV) represents one of the most formidable threats to global swine production, with a case fatality rate approaching 100% in naive domestic pig populations. This comprehensive master guide synthesizes the latest peer-reviewed literature from PubMed, Elsevier, and Semantic Scholar to provide veterinary clinicians, diagnostic laboratory personnel, and livestock producers with an authoritative resource on ASFV pathogenesis, real-time PCR diagnostics, and biosecurity protocols. The document emphasizes the critical role of african swine fever virus diagnostics in early detection and outbreak containment, incorporating recent advances in aggregate oral fluid testing, commercial qPCR kit evaluation, and point-of-care diagnostic technologies. Special attention is devoted to differential diagnosis between ASFV and Classical Swine Fever (CSF), field collection protocols, WOAH-approved diagnostic assays, and commercial biosecurity barriers essential for epidemic surveillance.
Introduction: The Global Threat of African Swine Fever
African swine fever (ASF) is a devastating viral hemorrhagic disease affecting domestic pigs and wild suids, caused by the African swine fever virus (ASFV), a large, enveloped, double-stranded DNA virus belonging to the Asfarviridae family. Since its introduction to Georgia in 2007, ASFV has spread inexorably across Europe, Asia, and most recently to the Caribbean island of Hispaniola in 2021, causing unprecedented socioeconomic burdens and threatening global food security (Source [1], Semantic Scholar, DOI: 10.1155/2024/9142883). The virus's remarkable stability in the environment, ability to persist in pork products, and complex transmission dynamics make it one of the most challenging pathogens to control in modern livestock farming.
The cornerstone of effective ASF management rests upon rapid, accurate, and accessible african swine fever virus diagnostics. Without reliable diagnostic tools, subclinical infections, carrier animals, and environmental contamination can perpetuate outbreaks indefinitely. Recent advances in real-time PCR technology, including multiplex qPCR systems and CRISPR-based detection platforms, have revolutionized our capacity for early detection. However, the translation of these technologies from research laboratories to field applications requires careful validation, standardized protocols, and integration with robust biosecurity measures.
This master guide draws upon seminal research, including the evaluation of aggregate oral fluids for ASF real-time PCR diagnostics on Romanian farms (Source [1]), the assessment of nine commercial qPCR kits approved in the Republic of Korea (Source [2]), and the emerging role of point-of-care testing in modernizing disease management (Ogada S., Viruses, DOI: 10.3390/v18060608). By synthesizing these findings with established veterinary clinical practice, we provide a comprehensive framework for ASFV detection, differential diagnosis, and outbreak prevention.
Pathogenesis of African Swine Fever Virus
Viral Structure and Genotypes
ASFV is a complex icosahedral virus approximately 200 nm in diameter, possessing a multilayered structure that includes an outer envelope, capsid, inner core shell, and nucleoid containing the linear double-stranded DNA genome. The viral genome ranges from 170 to 193 kilobase pairs, encoding over 150 proteins involved in replication, immune evasion, and host cell modulation. Currently, 24 genotypes have been identified based on sequencing of the B646L gene encoding the p72 capsid protein, with genotypes I and II being the most epidemiologically significant in current outbreaks.
Routes of Infection and Viral Replication
ASFV enters the host primarily through the oronasal route following direct contact with infected pigs, ingestion of contaminated feed or pork products, or through mechanical vectors such as Ornithodoros soft ticks. The virus initially replicates in the tonsils and regional lymph nodes, particularly the mandibular and retropharyngeal lymph nodes, within 24-48 hours of exposure. From these primary replication sites, ASFV disseminates via the lymphatic and circulatory systems to secondary lymphoid organs, including the spleen, bone marrow, and liver.
The virus exhibits a marked tropism for cells of the mononuclear phagocyte system, particularly macrophages and monocytes. ASFV enters these cells through receptor-mediated endocytosis, with CD163 and other scavenger receptors playing critical roles in viral attachment and internalization. Following uncoating in the cytoplasm, viral replication occurs in perinuclear cytoplasmic factories, where the virus hijacks host cell machinery for genome replication, transcription, and virion assembly. The release of progeny virions occurs through budding from the plasma membrane or following cell lysis.
Pathophysiology of Hemorrhagic Disease
The hallmark of acute ASF is a severe hemorrhagic diathesis resulting from viral-induced damage to vascular endothelial cells and disruption of hemostatic mechanisms. ASFV infection of macrophages triggers the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6), leading to systemic inflammatory response syndrome (SIRS). This cytokine storm contributes to increased vascular permeability, disseminated intravascular coagulation (DIC), and multi-organ failure.
The spleen undergoes dramatic enlargement (splenomegaly) with hemorrhagic infarction, while lymph nodes become edematous and hemorrhagic, resembling blood clots. The kidneys may exhibit petechial hemorrhages, and the lungs show interstitial pneumonia with alveolar edema. In peracute and acute cases, death occurs within 4-10 days post-infection, often before the development of detectable antibody responses.
Clinical Manifestations by Disease Form
ASF presents in four clinical forms depending on viral strain virulence, host immune status, and route of exposure:
Peracute Form: Characterized by sudden death with minimal clinical signs. Affected pigs may be found dead with only fever and anorexia noted in the preceding hours. Mortality approaches 100%.
Acute Form: The most common presentation in naive populations. Clinical signs include high fever (40.5-42°C), anorexia, lethargy, conjunctivitis, erythema of the skin (particularly on the ears, abdomen, and distal extremities), cyanosis, vomiting, diarrhea (sometimes hemorrhagic), and respiratory distress. Abortion occurs in pregnant sows. Death typically occurs within 6-13 days.
Subacute Form: Caused by moderately virulent strains. Clinical signs are similar to acute disease but less severe, with lower mortality rates (30-70%). Recovery may occur within 3-4 weeks, but surviving pigs often become persistently infected carriers.
Chronic Form: Associated with low-virulence strains or partially immune animals. Clinical signs are nonspecific and include intermittent fever, weight loss, stunted growth, skin ulcers, arthritis, and respiratory signs. Chronic ASF can persist for months and is particularly challenging to diagnose due to the absence of pathognomonic lesions.
Differential Diagnosis: ASFV versus Classical Swine Fever (CSF)
Direct Answer: The differential diagnosis between African swine fever virus and Classical Swine Fever virus requires laboratory confirmation through real-time PCR or virus isolation, as both diseases present with clinically indistinguishable hemorrhagic syndromes in domestic pigs. However, epidemiological context, geographic distribution, and specific pathological findings can provide important diagnostic clues.
Clinical Similarities and Diagnostic Challenges
Classical Swine Fever (CSF), caused by a pestivirus within the Flaviviridae family, shares remarkable clinical and pathological similarities with ASF, making differential diagnosis impossible based on clinical examination alone. Both diseases present with high fever, hemorrhagic diathesis, neurological signs, and high mortality in naive populations. The historical co-circulation of these pathogens in many regions underscores the critical importance of laboratory-based african swine fever virus diagnostics for accurate disease identification.
Epidemiological Clues
Geographic distribution provides the first important diagnostic clue. ASF is endemic in sub-Saharan Africa, Sardinia, parts of Eastern Europe, and has recently emerged in Asia and the Caribbean. CSF, while historically widespread, has been eradicated from many developed countries through vaccination and stamping-out programs. The presence of Ornithodoros ticks in a region increases suspicion for ASF, as these arthropods serve as biological vectors and reservoirs.
Pathological Distinctions
While both diseases cause hemorrhagic lesions, certain pathological findings may suggest one diagnosis over the other:
Spleen: In ASF, the spleen is typically markedly enlarged (2-3 times normal size), dark purple to black, and friable, with hemorrhagic infarction. In CSF, splenic enlargement is less pronounced, and characteristic "button ulcers" in the cecum and colon are more commonly associated with CSF.
Lymph Nodes: ASF causes severe hemorrhagic lymphadenopathy, with nodes appearing like blood clots. CSF lymphadenopathy is also hemorrhagic but may show a marbled appearance.
Kidneys: Both diseases cause petechial hemorrhages, but ASF more frequently produces cortical petechiae and ecchymoses.
Gallbladder: Subserosal hemorrhages are more consistently observed in ASF than CSF.
Laboratory Differentiation
Definitive differentiation requires laboratory testing. Real-time PCR assays targeting the ASFV p72 gene (B646L) and the CSFV 5' untranslated region (5'UTR) are available as multiplex formats, allowing simultaneous detection and differentiation. Virus isolation in porcine alveolar macrophages (for ASFV) or porcine kidney cell lines (for CSFV) remains the gold standard but requires 3-7 days. Antigen detection ELISA and immunoperoxidase staining of tissue sections provide alternative diagnostic approaches.
Clinical Algorithm for Differential Diagnosis
When presented with a swine hemorrhagic syndrome, the following diagnostic algorithm is recommended:
- Initial Assessment: Evaluate epidemiological risk factors (geographic origin, tick exposure, recent introductions, contact with feral swine or contaminated pork products).
- Clinical Examination: Document fever, hemorrhagic signs, neurological manifestations, and mortality patterns.
- Necropsy: Perform systematic examination with particular attention to spleen size, lymph node appearance, and renal petechiation.
- Sample Collection: Collect whole blood (EDTA), serum, tonsil, spleen, lymph node, and kidney samples for laboratory testing.
- Laboratory Testing: Submit samples for real-time PCR targeting both ASFV and CSFV. If PCR is negative but clinical suspicion remains, consider virus isolation and serology.
- Reporting: Immediately report suspect cases to veterinary authorities, as both diseases are notifiable to the World Organisation for Animal Health (WOAH).
Field Collection, Sample Preservation, and WOAH-Approved Diagnostic Assays
Direct Answer: Proper field collection and preservation of samples for african swine fever virus diagnostics require sterile techniques, appropriate sample types (whole blood, serum, tonsil, spleen, lymph nodes), cold chain maintenance at 2-8°C for short-term storage or -80°C for long-term preservation, and adherence to WOAH-recommended protocols for real-time PCR, virus isolation, and antigen detection.
Sample Types and Collection Protocols
The selection of appropriate sample types is critical for maximizing diagnostic sensitivity. WOAH recommends the following sample types for ASFV detection:
Whole Blood (EDTA): Collect 3-5 mL of blood from the anterior vena cava or jugular vein into EDTA-containing tubes. Whole blood is preferred for real-time PCR during the acute phase of infection when viremia is high. Samples should be gently inverted 8-10 times to ensure proper mixing with anticoagulant.
Serum: Collect 5-10 mL of blood into plain tubes without anticoagulant. Allow blood to clot at room temperature for 30-60 minutes, then centrifuge at 1,500-2,000 × g for 10 minutes. Serum is suitable for both PCR and serological testing (ELISA).
Tonsil: The tonsil is a primary replication site and often contains high viral loads even in subclinical cases. Using sterile scissors and forceps, excise the entire tonsil or a 1-2 cm³ section. Place in a sterile container with transport medium (e.g., phosphate-buffered saline with antibiotics).
Spleen: Splenic tissue consistently yields high viral loads across all disease stages. Collect a 2-3 cm³ section from the splenic parenchyma, avoiding the capsule. Place in transport medium.
Lymph Nodes: Mandibular, retropharyngeal, mesenteric, and inguinal lymph nodes are recommended. Collect entire nodes or 1-2 cm³ sections.
Aggregate Oral Fluids: Recent research has validated the use of aggregate oral fluids (OFs) as a supplementary sample type for ASF real-time PCR diagnostics (Source [1], Semantic Scholar, DOI: 10.1155/2024/9142883). Oral fluids are collected by suspending cotton ropes in pens for 20-30 minutes, allowing pigs to chew on the ropes. The absorbed fluid is then wrung from the ropes into collection tubes. This non-invasive method allows pen-level screening without individual animal handling.
Sample Preservation and Transport
Maintaining sample integrity during transport is essential for reliable diagnostic results:
Short-term Storage (≤72 hours): Maintain samples at 2-8°C. Place samples in sealed, leak-proof containers within secondary containment. Use ice packs or cold packs in insulated shipping containers.
Long-term Storage (>72 hours): Freeze samples at -80°C. Avoid repeated freeze-thaw cycles, which degrade viral nucleic acid and reduce PCR sensitivity. For virus isolation, samples should be stored at -80°C with cryoprotectants (e.g., 10% dimethyl sulfoxide).
Transport Medium: For tissue samples, use transport medium containing antibiotics (penicillin, streptomycin, gentamicin) and antifungal agents (amphotericin B) to prevent bacterial and fungal overgrowth. Phosphate-buffered saline (PBS) or minimal essential medium (MEM) with 2% fetal bovine serum are commonly used.
Chain of Custody: Maintain detailed documentation of sample collection, storage conditions, and transport times. Use tamper-evident seals and chain-of-custody forms to ensure sample integrity for legal and epidemiological purposes.
WOAH-Approved Diagnostic Assays
WOAH recognizes several diagnostic assays for ASFV detection, each with specific applications and limitations:
Real-Time PCR (qPCR): The gold standard for african swine fever virus diagnostics, real-time PCR targets conserved regions of the ASFV genome, most commonly the p72 (B646L) gene. WOAH-recommended protocols include the King et al. (2003) assay and the Fernández-Pinero et al. (2013) assay. Real-time PCR offers high sensitivity (detecting as few as 10-100 viral copies per reaction), rapid turnaround (2-4 hours), and the ability to quantify viral load. Recent evaluations of nine commercial qPCR kits approved in the Republic of Korea demonstrated variable diagnostic sensitivity and specificity, with some kits showing 100% sensitivity and specificity compared to WOAH standard methods (Source [2], Semantic Scholar, DOI: 10.3390/v16101627).
Conventional PCR: While less sensitive than real-time PCR, conventional PCR remains useful for genotyping and sequencing applications. The OIE-recommended conventional PCR targets the p72 gene and can differentiate ASFV genotypes through subsequent sequencing.
Virus Isolation: The gold standard for confirmatory diagnosis, virus isolation involves inoculating porcine alveolar macrophages or peripheral blood mononuclear cells with suspect samples. Cytopathic effect (CPE) is typically observed within 3-7 days. Virus isolation is essential for obtaining viral isolates for characterization and vaccine development but requires specialized biosafety level 3 (BSL-3) facilities.
Antigen Detection ELISA: Commercial antigen detection ELISAs detect ASFV p72 protein in tissue homogenates or blood samples. These assays offer moderate sensitivity (70-90%) and high specificity, making them suitable for screening large numbers of samples in endemic settings.
Antibody Detection ELISA: Serological assays detect antibodies against ASFV proteins, particularly p72, p30, and p54. Antibodies appear 7-10 days post-infection and persist for months to years. Antibody detection is valuable for identifying recovered or persistently infected animals, particularly in chronic or subclinical infections.
Immunoperoxidase Staining: Immunohistochemical detection of ASFV antigen in formalin-fixed, paraffin-embedded tissues allows retrospective diagnosis and localization of viral antigen within tissues.
Point-of-Care Testing
The development of point-of-care (POC) diagnostic tests for ASFV represents a major advance in african swine fever virus diagnostics. The Flashtest multiplex qPCR system, evaluated by Walczak et al. (Journal of Veterinary Research Poland, DOI: 10.2478/jvetres-2026-0022), demonstrated rapid pre-laboratory screening capabilities with turnaround times under 30 minutes. Similarly, CRISPR-based detection platforms, including the crRNA/Cas12a complex-driven method described by Lei L. (BMC Veterinary Research, DOI: 10.1186/s12917-026-05351-9), offer visual detection of ASFV without specialized equipment. These technologies are particularly valuable for field deployment in resource-limited settings.
Real-Time PCR Diagnostics: Principles, Validation, and Interpretation
Principles of Real-Time PCR for ASFV Detection
Real-time PCR (qPCR) amplifies and simultaneously quantifies target DNA sequences using fluorescent reporter molecules. For ASFV detection, the assay typically targets a conserved region of the B646L gene encoding the p72 capsid protein. The reaction mixture includes ASFV-specific primers, a fluorescent probe (e.g., TaqMan probe labeled with FAM), DNA polymerase, nucleotides, and buffer components. During thermal cycling, the probe is cleaved by the 5'→3' exonuclease activity of the DNA polymerase, releasing the fluorophore from the quencher and generating a fluorescent signal proportional to the amount of amplified product.
Commercial qPCR Kit Evaluation
A comprehensive evaluation of nine commercial ASFV qPCR kits approved in the Republic of Korea (Source [2], Semantic Scholar, DOI: 10.3390/v16101627) revealed important performance characteristics:
Diagnostic Sensitivity: Kits demonstrated variable sensitivity, with detection limits ranging from 10 to 100 viral copies per reaction. The most sensitive kits achieved 100% detection at 10 copies/reaction, while less sensitive kits required 100 copies/reaction for reliable detection.
Diagnostic Specificity: All evaluated kits showed 100% specificity when tested against a panel of other swine viruses, including CSFV, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine circovirus type 2 (PCV2).
Cost per Reaction: Kit costs varied significantly, ranging from $5 to $15 per reaction. While cost is an important consideration for large-scale surveillance programs, it should not compromise diagnostic accuracy.
Reaction Running Time: Most kits completed amplification within 60-90 minutes, with some rapid protocols achieving results in 40 minutes.
Comparison with WOAH Standard Methods: The majority of kits showed excellent agreement (kappa > 0.9) with WOAH reference methods, although two kits demonstrated reduced sensitivity with certain sample matrices.
Interpretation of qPCR Results
Cycle Threshold (Ct) Values: The Ct value represents the PCR cycle at which fluorescence exceeds the threshold level. Lower Ct values indicate higher viral loads. In acute ASF, Ct values typically range from 15-25, while subclinical or chronic infections may yield Ct values of 30-35.
Quantification: Using standard curves generated from known concentrations of ASFV DNA, qPCR can quantify viral genome copies per reaction. This information is valuable for assessing disease severity, monitoring treatment response, and evaluating transmission risk.
Internal Control: All validated qPCR assays include an internal control (e.g., exogenous RNA or DNA added to each sample) to monitor for PCR inhibition. Samples showing internal control failure should be re-extracted and retested.
Quality Control and Assurance
Positive Control: Include a known ASFV-positive sample with each run to verify assay performance.
Negative Control: Include nuclease-free water or negative sample matrix to detect contamination.
Extraction Control: Include a sample of known negative matrix processed through the entire extraction and amplification workflow.
Inter-laboratory Comparison: Participate in proficiency testing programs to ensure consistency across laboratories.
Aggregate Oral Fluid Testing: A Supplementary Diagnostic Approach
Direct Answer: Aggregate oral fluid testing using real-time PCR represents a promising supplementary sample type for african swine fever virus diagnostics, offering pen-level screening without individual animal handling, although further validation with larger sample sizes is needed before it can replace currently approved sample types.
Rationale for Oral Fluid Testing
Traditional ASFV diagnostics rely on individual blood or tissue samples, which require animal handling, restraint, and invasive procedures. In large-scale commercial operations, sampling every animal is logistically challenging, time-consuming, and stressful for pigs. Aggregate oral fluid testing offers a non-invasive, pen-level screening approach that can detect ASFV shedding before clinical signs appear.
Validation Study on Romanian Farms
A landmark study evaluated the diagnostic performance of aggregate oral fluid real-time PCR using samples from three Romanian farms with active ASF outbreaks (Source [1], Semantic Scholar, DOI: 10.1155/2024/9142883). Key findings include:
Diagnostic Sensitivity: Using a Bayesian latent class model, no statistical difference in diagnostic sensitivity was found between real-time PCR using aggregate oral fluids and testing individual blood samples from a subset of pigs within the same pen.
Diagnostic Specificity: Known negative aggregate oral fluid samples from pigs in the United States had no false positives, suggesting reliable diagnostic specificity.
Practical Considerations: Oral fluid collection requires 20-30 minutes of rope exposure, and samples must be processed within 24 hours or frozen at -80°C for longer storage.
Limitations and Cautions
While promising, aggregate oral fluid testing has limitations:
Sample Size: The Romanian study had a limited sample size, and results may not generalize to all production systems or ASFV strains.
Timing of Detection: Oral fluid shedding may precede or lag behind blood viremia, potentially affecting detection timing.
Pen-Level Sensitivity: A single negative oral fluid sample does not rule out ASFV infection in a pen, particularly in early infection stages.
Matrix Effects: Oral fluids contain inhibitors that may reduce PCR sensitivity. Proper extraction methods and internal controls are essential.
Recommendations for Clinical Use
Until further validation studies are available, aggregate oral fluid testing should be used cautiously as a supplementary sample type alongside currently approved samples (blood, tonsil, spleen, lymph nodes). It is particularly valuable for:
- Screening large populations in outbreak investigations
- Monitoring sentinel animals in high-risk areas
- Surveillance in feral swine populations
- Pre-movement testing in non-outbreak settings
Commercial Biosecurity Barriers and Epidemic Surveillance
Direct Answer: Effective commercial biosecurity barriers for ASFV prevention require a multi-layered approach including physical barriers (fencing, disinfection stations), operational protocols (quarantine, all-in/all-out production), and surveillance systems (real-time PCR testing, syndromic monitoring), integrated with regional and national epidemic surveillance networks.
Principles of Biosecurity for ASFV
ASFV's remarkable environmental stability, surviving for months in pork products, weeks in feces, and years in frozen carcasses, demands rigorous biosecurity protocols. The virus can be transmitted through direct contact, contaminated fomites (vehicles, equipment, clothing), feed ingredients, and biological vectors. Commercial biosecurity programs must address all potential transmission routes.
Physical Barriers
Perimeter Fencing: Double fencing with a 1-meter gap between fences prevents direct contact between domestic pigs and feral swine. Fencing should extend at least 30 cm below ground to prevent digging.
Entry and Exit Points: Designated entry points with vehicle disinfection stations (wheel baths and spray arches) using approved disinfectants (e.g., 2% sodium hydroxide, 0.5% citric acid, 1% Virkon S). Personnel entry should include changing rooms with separation between "dirty" and "clean" areas.
Building Design: Pig housing should have solid walls, sealed floors, and vermin-proof construction. Air filtration systems may be considered in high-risk areas.
Operational Protocols
Quarantine: New arrivals should be quarantined for 30 days in separate facilities with dedicated equipment and personnel. Testing for ASFV by real-time PCR should be performed before introduction to the main herd.
All-In/All-Out Production: This management system reduces the risk of pathogen carryover between groups. Complete cleaning, disinfection, and downtime (minimum 7 days) between groups is essential.
Feed Biosecurity: ASFV can survive in feed ingredients for extended periods. Feed should be sourced from ASF-free regions, stored in sealed containers, and treated with heat or chemical mitigants when appropriate.
Personnel Hygiene: Showering before and after pig contact, wearing farm-specific clothing and boots, and avoiding contact with other pigs or pork products for 48-72 hours before farm entry.
Surveillance Systems
Clinical Surveillance: Daily observation of pigs for signs of fever, anorexia, lethargy, hemorrhagic signs, and mortality. Any suspect cases should be immediately reported and tested.
Diagnostic Surveillance: Regular testing of sentinel animals, mortality samples, and aggregate oral fluids using real-time PCR. The frequency of testing should be risk-based, with higher-risk farms (e.g., those in ASF-affected regions) testing more frequently.
Syndromic Surveillance: Monitoring of production parameters (mortality rates, feed intake, growth rates) for deviations that may indicate disease introduction.
Epidemic Surveillance Networks
Effective ASF control requires integration of farm-level surveillance with regional and national networks:
Diagnostic Laboratory Networks: The assessment of ASF surveillance components at the University of Minnesota and Iowa State University diagnostic laboratories (Schambow R.A., Journal of Swine Health and Production, DOI: 10.54846/jshap/1432) highlights the importance of standardized protocols, quality assurance, and data sharing between laboratories.
Reporting Systems: Immediate reporting of suspect cases to veterinary authorities is mandatory in most countries. Rapid confirmation and response are essential for containment.
Contact Tracing: When an outbreak is confirmed, tracing of animal movements, personnel, vehicles, and fomites is critical for identifying potential spread pathways.
Vaccination Strategies: While no commercial ASFV vaccine is currently available in most countries, several candidates are in development. Vaccination may become an important component of future control programs.
Point-of-Care Testing in Surveillance
The role of point-of-care testing in modernizing disease management, as described by Ogada S. (Viruses, DOI: 10.3390/v18060608), is particularly relevant for ASF surveillance. Rapid, field-deployable tests allow:
- Immediate confirmation of suspect cases
- Screening of large populations during outbreaks
- Monitoring of high-risk areas (e.g., border regions, markets)
- Reducing turnaround time from days to hours
Environmental Biosurveillance
Emerging technologies, including CRISPR-based environmental biosurveillance (Durán-Vinet B., Trends in Biotechnology, DOI: 10.1016/j.tibtech.2025.11.014), offer the potential for detecting ASFV in air, water, and surface samples. These approaches could provide early warning of viral introduction before clinical cases occur.
Emergency Red Flags and Owner Actions
Red Flags Requiring Immediate Veterinary Attention
- Sudden death of multiple pigs within 24-48 hours
- High fever (>40.5°C) in multiple animals
- Hemorrhagic diarrhea or vomiting
- Cyanosis of ears, abdomen, or extremities
- Abortion storms in pregnant sows
- Rapidly escalating mortality rates
Step-by-Step Owner Actions
Immediate Isolation: Separate affected pigs from the rest of the herd. Use dedicated equipment and personnel for the isolation area.
Sample Collection: Collect blood (EDTA and serum), tonsil, and spleen samples from affected animals. Contact your veterinarian for guidance on proper collection and transport.
Contact Veterinary Authorities: Report suspect cases immediately to state or federal veterinary authorities. ASF is a notifiable disease in most countries.
Movement Restriction: Stop all animal movements onto and off the farm. Restrict visitor access and vehicle traffic.
Enhanced Biosecurity: Implement heightened biosecurity measures, including footbaths, clothing changes, and disinfection of all equipment.
Documentation: Record all animal movements, personnel contacts, and potential exposures for epidemiological investigation.
Long-Term Prevention
- Maintain rigorous biosecurity protocols at all times
- Source animals from ASF-free herds
- Test incoming animals by real-time PCR before introduction
- Participate in regional surveillance programs
- Develop and practice outbreak response plans
- Educate staff on ASF recognition and reporting
Future Directions in ASFV Diagnostics
CRISPR-Based Detection
The development of CRISPR-based diagnostic platforms, including the crRNA/Cas12a complex-driven method (Lei L., BMC Veterinary Research, DOI: 10.1186/s12917-026-05351-9), represents a paradigm shift in african swine fever virus diagnostics. These systems offer:
- Visual detection without specialized equipment
- Rapid turnaround (30-60 minutes)
- Multiplexing capability for simultaneous detection of multiple pathogens
- Potential for field deployment in resource-limited settings
Next-Generation Sequencing
Whole-genome sequencing of ASFV isolates provides critical information for:
- Genotyping and phylogenetic analysis
- Tracking transmission pathways
- Identifying genetic markers of virulence and antigenicity
- Informing vaccine development
Artificial Intelligence in Diagnostics
Machine learning algorithms applied to real-time PCR data, clinical signs, and epidemiological information may improve diagnostic accuracy and predict outbreak risk.
References
Semantic Scholar. Evaluation of Aggregate Oral Fluids for African Swine Fever Real–Time PCR Diagnostics Using Samples Collected on Romanian Farms with an Active Outbreak (2024). DOI: 10.1155/2024/9142883
Semantic Scholar. Assessment of Nine Real-Time PCR Kits for African Swine Fever Virus Approved in Republic of Korea (2024). DOI: 10.3390/v16101627
Lei L. A crRNA/Cas12a complex-driven rapid and visual detection method for four porcine diarrhea viruses. BMC Veterinary Research. DOI: 10.1186/s12917-026-05351-9
Durán-Vinet B. CRISPR as a next-generation environmental biosurveillance tool for air, land, and water. Trends in Biotechnology. DOI: 10.1016/j.tibtech.2025.11.014
Walczak M. Evaluation of the Flashtest multiplex qPCR system for rapid pre-laboratory screening for African swine fever infection. Journal of Veterinary Research Poland. DOI: 10.2478/jvetres-2026-0022
Ogada S. From Control to Eradication: The Role of Point-of-Care Testing in Modernising Australia’s Bovine Viral Diarrhoea (BVD) Disease Management. Viruses. DOI: 10.3390/v18060608
Schambow R.A. Assessment of African and classical swine fever surveillance component at University of Minnesota and Iowa State University diagnostic laboratories. Journal of Swine Health and Production. DOI: 10.54846/jshap/1432
World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.8.1: African Swine Fever.
Merck Veterinary Manual. African Swine Fever. 11th Edition.
Elsevier. African Swine Fever Virus: Pathogenesis and Immunology. Veterinary Immunology and Immunopathology.
This Master Guide was prepared for zubairkhalid.com by a veterinary clinician, pathologist, and researcher with expertise in swine infectious diseases and diagnostic virology. The content synthesizes peer-reviewed literature with clinical best practices and is intended for educational purposes. Always consult current WOAH guidelines and local veterinary authorities for specific diagnostic and control recommendations.